The BioPlex 2200 Vasculitis kit is for use on the BioPlex 2200 system, a platform that employs multiplexing technology to analyse multiple disease markers from a single patient sample
Bio-Rad Laboratories has announced the launch of the first and only fully automated, random access multiplex test system for autoimmune systemic vasculitis testing.
Vasculitis is an autoimmune disease in which the body's immune system mistakenly attacks its own blood vessels causing them to become inflamed.
The disruption of blood flow can result in damage to a body's organs.
Through simultaneous identification and semi-quantitative detection of three of the most clinically relevant vasculitis autoantibodies, the BioPlex 2200 Vasculitis kit can be used to help diagnose some of the most severe autoimmune vasculitis diseases.
"The release of the Vasculitis kit is another example of Bio-Rad's continued commitment to provide laboratories with more useful information, highly reproducible results, and faster result turnaround time," said John Goetz, Bio-Rad vice president and group manager clinical diagnostics.
"Using the Vasculitis kit, physicians are able to offer enhanced patient management while optimising their operational efficiencies and reducing costs".
The BioPlex 2200 system is the first and only fully automated, random access multiplex testing system and provides clinical laboratories with the capability to rapidly process (multiplex) multiple individual tests, which are traditionally processed separately, using a single small volume patient sample.
